[go: up one dir, main page]

NO944781L - 2,5-diokso-2,5-dihydro-1H-benz(b)azepiner som NMDA-reseptor-antagonister - Google Patents

2,5-diokso-2,5-dihydro-1H-benz(b)azepiner som NMDA-reseptor-antagonister

Info

Publication number
NO944781L
NO944781L NO944781A NO944781A NO944781L NO 944781 L NO944781 L NO 944781L NO 944781 A NO944781 A NO 944781A NO 944781 A NO944781 A NO 944781A NO 944781 L NO944781 L NO 944781L
Authority
NO
Norway
Prior art keywords
benz
azepines
dioxo
dihydro
receptor antagonists
Prior art date
Application number
NO944781A
Other languages
English (en)
Other versions
NO944781D0 (no
NO305168B1 (no
Inventor
Marc Jerome Chapdelaine
Gregory David Harris
Paul Francis Jackson
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of NO944781D0 publication Critical patent/NO944781D0/no
Publication of NO944781L publication Critical patent/NO944781L/no
Publication of NO305168B1 publication Critical patent/NO305168B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NO944781A 1992-06-10 1994-12-09 2,5-diokso-2,5-dihydro-1H-benz(b)azepiner og farmas°ytiske blandinger inneholdende dem NO305168B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929212308A GB9212308D0 (en) 1992-06-10 1992-06-10 Therapeutic compositions
PCT/GB1993/001218 WO1993025534A1 (en) 1992-06-10 1993-06-09 2,5-DIOXO-2,5-DIHYDRO-1H-BENZ[b]AZEPINES AS NMDA RECEPTOR ANTAGONISTS

Publications (3)

Publication Number Publication Date
NO944781D0 NO944781D0 (no) 1994-12-09
NO944781L true NO944781L (no) 1995-01-30
NO305168B1 NO305168B1 (no) 1999-04-12

Family

ID=10716859

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944781A NO305168B1 (no) 1992-06-10 1994-12-09 2,5-diokso-2,5-dihydro-1H-benz(b)azepiner og farmas°ytiske blandinger inneholdende dem

Country Status (18)

Country Link
US (3) US5492905A (no)
EP (1) EP0644878B1 (no)
JP (1) JPH09502157A (no)
KR (1) KR100298377B1 (no)
AT (1) ATE205480T1 (no)
AU (1) AU672799B2 (no)
CA (1) CA2137834A1 (no)
DE (1) DE69330754T2 (no)
DK (1) DK0644878T3 (no)
ES (1) ES2161718T3 (no)
FI (2) FI106714B (no)
GB (1) GB9212308D0 (no)
HU (1) HUT71404A (no)
NO (1) NO305168B1 (no)
NZ (1) NZ253252A (no)
PT (1) PT644878E (no)
RU (1) RU94046322A (no)
WO (1) WO1993025534A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9212308D0 (en) * 1992-06-10 1992-07-22 Ici Plc Therapeutic compositions
GB9311948D0 (en) * 1993-06-10 1993-07-28 Zeneca Ltd Substituted nitrogen heterocycles
US5476933A (en) * 1994-11-16 1995-12-19 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Azepine synthesis via a diels-alder reaction
MY133587A (en) 2002-05-29 2007-11-30 Glaxo Group Ltd Aromatic sulfones and their medical use
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
EP2089383B1 (en) 2006-11-09 2015-09-16 Probiodrug AG 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
US9126987B2 (en) 2006-11-30 2015-09-08 Probiodrug Ag Inhibitors of glutaminyl cyclase
EP2481408A3 (en) 2007-03-01 2013-01-09 Probiodrug AG New use of glutaminyl cyclase inhibitors
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
KR101853026B1 (ko) 2008-10-22 2018-04-27 어레이 바이오파마 인크. ＴＲＫ 키나아제 억제제로서 치환된 피라졸로［１,５­ａ］ 피리미딘 화합물
CA2772488C (en) 2009-09-11 2018-04-17 Probiodrug Ag Heterocyclic derivatives as inhibitors of glutaminyl cyclase
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
NZ602312A (en) 2010-03-10 2014-02-28 Probiodrug Ag Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
JP5945532B2 (ja) 2010-04-21 2016-07-05 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体
EP2686313B1 (en) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazole derivatives as inhibitors of glutaminyl cyclase
WO2016199789A1 (ja) * 2015-06-08 2016-12-15 国立大学法人名古屋大学 トリフルオロメチル置換セミスクアレートの製造方法、トリフルオロメチル置換セミスクアレートを起点とするトリフルオロメチル化合物の製造方法及びトリフルオロメチル基含有化合物
SI3458456T1 (sl) * 2016-05-18 2021-04-30 Loxo Oncology, Inc. Priprava (S)-N-(5-((R)-2-(2,5-difluorofenil) pirolidin-1-il) pirazolo (1,5-A) pirimidin-3-il)-3-hidroksipirolidin-1-karboksamida
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB130538A (en) * 1918-12-13 1919-08-07 John Algernon Launder Improvements in or relating to Means for Supporting Garments and Garment Hangers.
GB1340334A (en) * 1970-07-06 1973-12-12 Rees A H Synthesis of benzazetropolones and hence of kynurenic acids
JPS5129522B2 (no) * 1972-07-13 1976-08-26
JPS5520970B2 (no) * 1972-07-15 1980-06-06
EP0072352B1 (de) * 1981-08-11 1986-03-05 Ciba-Geigy Ag Benzazepin-2-one, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese Verbindungen enthalten, sowie die Verbindungen zur therapeutischen Verwendung
US4410520A (en) * 1981-11-09 1983-10-18 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4473575A (en) * 1982-07-19 1984-09-25 Ciba-Geigy Corporation 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
US4575503A (en) * 1983-02-10 1986-03-11 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
DE3323568C2 (de) * 1983-06-30 1987-01-29 Bayerische Motoren Werke AG, 8000 München Heiz- und/oder Klimaanlage für Kraftfahrzeuge
US4477446A (en) * 1983-07-01 1984-10-16 Usv Pharmaceutical Corporation 1-Benzazepines and their pharmaceutical uses
DE3416695A1 (de) * 1984-05-05 1985-11-07 Bayer Ag, 5090 Leverkusen Amidinohydrazone von tetralin-, chromon-, thiochromon- und tretrahydrochinolin-derivaten, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
WO1991005549A1 (en) * 1989-10-20 1991-05-02 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
GB9100028D0 (en) * 1991-01-02 1991-02-20 Ici Plc Compounds
JPH05105292A (ja) * 1991-10-15 1993-04-27 Nec Corp ロール紙のカール解消装置
GB9212308D0 (en) * 1992-06-10 1992-07-22 Ici Plc Therapeutic compositions
DE69334237D1 (de) * 1992-06-22 2008-09-25 State Of Oregon Through Oregon Glycinrezeptorantagonisten und ihre verwendung
GB9311948D0 (en) * 1993-06-10 1993-07-28 Zeneca Ltd Substituted nitrogen heterocycles

Also Published As

Publication number Publication date
NO944781D0 (no) 1994-12-09
RU94046322A (ru) 1996-11-10
US5712272A (en) 1998-01-27
FI20002725L (fi) 2000-12-12
AU4343693A (en) 1994-01-04
FI945807A7 (fi) 1994-12-09
ES2161718T3 (es) 2001-12-16
CA2137834A1 (en) 1993-12-23
DE69330754D1 (de) 2001-10-18
WO1993025534A1 (en) 1993-12-23
FI945807A0 (fi) 1994-12-09
EP0644878A1 (en) 1995-03-29
DE69330754T2 (de) 2002-07-04
US5492905A (en) 1996-02-20
GB9212308D0 (en) 1992-07-22
AU672799B2 (en) 1996-10-17
ATE205480T1 (de) 2001-09-15
NZ253252A (en) 1996-11-26
KR100298377B1 (ko) 2001-12-01
JPH09502157A (ja) 1997-03-04
PT644878E (pt) 2002-02-28
FI20002725A7 (fi) 2000-12-12
NO305168B1 (no) 1999-04-12
EP0644878B1 (en) 2001-09-12
HUT71404A (en) 1995-11-28
FI106714B (fi) 2001-03-30
DK0644878T3 (da) 2002-03-18
US5654295A (en) 1997-08-05

Similar Documents

Publication Publication Date Title
NO944781D0 (no) 2,5-diokso-2,5-dihydro-1H-benz(b)azepiner som NMDA-reseptor-antagonister
UA29416C2 (uk) Похідні 1,5 - бензодіазепіну, що є антагоністами гастрину та холецистокініну, спосіб їх одержання, фармацевтична композиція
NZ223772A (en) Substituted benzodiazepine derivatives and pharmaceutical compositions
IL127244A (en) Substituted amines, methods of their preparation and pharmaceutical compositions containing them
MX9605023A (es) Compuestos substituidos de imidazolidin-2,4-diona como substancias farmaceuticamente activas.
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
IL104853A (en) Benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them
IL117824A (en) Pharmaceutical compositions containing 2-aryl-imidazol¬1,2-a¾pyridine-3-acetamide derivatives for treatment of neuropsychiatric syndromes associated with dysfunction of the neural circuits of the basal ganglia
IL101358A0 (en) Crystalline tiagabine hydrochloride monohydrate,its preparation and pharmaceutical compositions containing it
IL113365A (en) 5-Heterocyclo-1,5-benzodiazepine derivatives their preparation and pharmaceutical compositions containing them
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
IL101514A0 (en) Cholecystokinin antagonists and pharmaceutical compositions containing them
GR3034354T3 (en) IMIDAZO 1,2-a]QUINOXALIN-4-AMINES ACTIVE AS ADENOSINE ANTAGONISTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF
BG102229A (en) Endothelium receptor antagonists
ITTO930661A1 (it) Derivati acidi poliamidici ad attivita' antigastrinica, procedimento per la loro preparazione e loro uso farmaceutico.
IL102880A0 (en) Hexahydrobenzo(f)quinolinones
HUP0004362A2 (hu) Karbamazepint vagy származékait tartalmazó parenterális készítmények
AU5768298A (en) Use of benzoylalkyl-1,2,3,6-tetrahydropyridins
HUP0001832A3 (en) Polycyclic phthalazin derivatives, their use for ppolycyclic phthalazin derivatives, their use for producing pharmaceutical compositions and pharmaceuroducing pharmaceutical compositions and pharmaceutical compositions containing the compounds tical compositions containing the compounds
FR2707648B1 (fr) Antagonistes de la Cholecystokinine, leur procédé de préparation et les compositions pharmaceutiques les comprenant.
UA27715C2 (uk) Похідні лактаму та фармацевтична композиція, яка є антагоністом 5-окситриптоміну /5-нт/ на 5-нт рецепторах